Local Institution

Rostock 18107

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Acute Coronary Syndromes, Advanced Cutaneous Melanoma, Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, Giant Cell Arteritis, Myeloid Leukemia, Chronic, Various Advanced Cancer

Studies at this site

• A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer — Completed
• Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting — Completed
• A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma — Completed
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA) — Withdrawn before enrolling
• A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia — Completed
• Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib — Completed
• Phase III Acute Coronary Syndrome — Stopped early